Biblio Discovery — Demo Discovery Service

37 results for "Amy Herman-Roloff"

Showing 21–37 · 0.00 seconds · RSS

  1. Journal Article Full text

    First cases of SARS-CoV-2 infection and secondary transmission in Kisumu, Kenya

    Beth A. Tippett Barr; Amy Herman-Roloff; Margaret Mburu et al.

    PLOS Global Public Health, Vol. 2 No. 9 · 2022 · English · PLOS Scopus

    We investigated the first 152 laboratory-confirmed SARS-CoV-2 cases (125 primary and 27 secondary) and their 248 close contacts in Kisumu County, Kenya. Conducted June 10–October 8, 2020, this study included interviews and sample collection at enrolment and 14–21 days later. Median age was 35 years…

    Also available at: DOAJ, DOAJ

  2. Journal Article

    Early warning and response systems for respiratory disease outbreaks: lessons learnt from cluster-associated cases of acute respiratory illnesses in Gilgil subcounty, Nakuru County, Kenya, 2021

    Linus Ndegwa; Philip Ngere; Lyndah Makayotto et al.

    BMJ Global Health, Vol. 10 No. 2 · 2025 · English · DOAJ Scopus

    Investigating acute respiratory illnesses (ARIs) is difficult due to non-specific symptoms, varied health-seeking behaviors, and resource limitations; yet early detection is critical to global health security. Kenya's Ministry of Health (MOH) uses the Integrated Disease Surveillance strategy for…

  3. Journal Article Full text

    Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation

    Jack Karuga Irungu; Peninah Munyua; Caroline Ochieng et al.

    PLOS ONE, Vol. 18 No. 1 · 2023 · English · PLOS Scopus

    Background: Accurate and timely diagnosis is essential in limiting the spread of SARS-CoV-2 infection. The reference standard, rRT-PCR, requires specialized laboratories, costly reagents, and a long turnaround time. Antigen RDTs provide a feasible alternative to rRT-PCR since they are quick…

    Also available at: DOAJ, DOAJ

  4. Journal Article

    Outbreak of Serotype 1 Invasive Pneumococcal Disease, Kibera Urban Informal Settlement, Nairobi, Kenya, 2023

    Terry Komo; Patrick K. Munywoki; Maria da Gloria Carvalho et al.

    Emerging Infectious Diseases, Vol. 31 No. 2 · 2025 · English · DOAJ Scopus

    Use of 10-valent pneumococcal conjugate vaccine in Kenya has led to substantial reductions in vaccine-type pneumococcal carriage and invasive pneumococcal disease. However, analysis of recent surveillance data indicates an outbreak of vaccine-type serotype 1 in 2023 in Kibera, Kenya. Continued…

  5. Journal Article

    Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021 [version 2; peer review: 1 approved, 2 approved with reservations]

    Peninah Munyua; Terrence Q. Lo; Amy Herman-Roloff et al.

    Gates Open Research, Vol. 7 · 2023 · English · DOAJ Scopus

    Background: SARS-CoV-2 has extensively spread in cities and rural communities, and studies are needed to quantify exposure in the population. We report seroprevalence of SARS-CoV-2 in two well-characterized populations in Kenya at two time points. These data inform the design and delivery of public…

  6. Journal Article

    Adapting Longstanding Public Health Collaborations between Government of Kenya and CDC Kenya in Response to the COVID-19 Pandemic, 2020–2021

    Amy Herman-Roloff; Rashid Aman; Taraz Samandari et al.

    Emerging Infectious Diseases, Vol. 28 No. 13 · 2022 · English · DOAJ Scopus

    Kenya’s Ministry of Health (MOH) and the US Centers for Disease Control and Prevention in Kenya (CDC Kenya) have maintained a 40-year partnership during which measures were implemented to prevent, detect, and respond to disease threats. During the COVID-19 pandemic, the MOH and CDC Kenya rapidly…

  7. Journal Article

    Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020 [version 2; peer review: 2 approved]

    Terrence Q Lo; Elizabeth Hunsperger; Amy Herman-Roloff et al.

    F1000Research, Vol. 10 · 2022 · English · DOAJ Scopus

    Introduction: Urban informal settlements may be disproportionately affected by the COVID-19 pandemic due to overcrowding and other socioeconomic challenges that make adoption and implementation of public health mitigation measures difficult. We conducted a seroprevalence survey in the Kibera…

  8. Journal Article

    Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults

    Taraz Samandari; Joshua B. Ongalo; Kimberly D. McCarthy et al.

    The Journal of Clinical Investigation, Vol. 133 No. 13 · 2023 · English · DOAJ Scopus

    Background SARS-CoV-2 infection in Africa has been characterized by a less severe disease profile than what has been observed elsewhere, but the profile of SARS-CoV-2–specific adaptive immunity in these mainly asymptomatic patients has not, to our knowledge, been analyzed.Methods We collected blood…

  9. Journal Article

    High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya

    Isaac Ngere; Jeanette Dawa; Elizabeth Hunsperger et al.

    International Journal of Infectious Diseases, Vol. 112 · 2021 · English · DOAJ Scopus

    ABSTRACT: Background: The lower than expected COVID-19 morbidity and mortality in Africa has been attributed to multiple factors, including weak surveillance. This study estimated the burden of SARS-CoV-2 infections eight months into the epidemic in Nairobi, Kenya. Methods: A population-based…

  10. Journal Article Full text

    Outbreak of Middle East Respiratory Syndrome Coronavirus in Camels and Probable Spillover Infection to Humans in Kenya

    Isaac Ngere; Elizabeth A. Hunsperger; Suxiang Tong et al.

    Viruses, Vol. 14 No. 8 · 2022 · English · DOAJ Scopus

    The majority of Kenya’s > 3 million camels have antibodies against Middle East respiratory syndrome coronavirus (MERS-CoV), although human infection in Africa is rare. We enrolled 243 camels aged 0–24 months from 33 homesteads in Northern Kenya and followed them between April 2018 to March 2020. We…

  11. Journal Article

    Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration [version 2; peer review: 2 approved]

    Peninah Munyua; J. Anthony G. Scott; Amy Herman-Roloff et al.

    Gates Open Research, Vol. 8 · 2025 · English · DOAJ Scopus

    The Kenya Multi Site Serosurveillance (KEMIS) collaboration set out to implement an integrated, nationally representative, population-based program of serological surveillance for past infection for a number of important infectious diseases in Kenya. The project started in December 2021 and built…

  12. Journal Article Full text

    Improving water, sanitation, and hygiene (WASH), with a focus on hand hygiene, globally for community mitigation of COVID-19

    David Berendes; Andrea Martinsen; Matthew Lozier et al.

    PLOS Water, Vol. 1 No. 6 · 2022 · English · PLOS Scopus

    Continuity of key water, sanitation, and hygiene (WASH) infrastructure and WASH practices—for example, hand hygiene—are among several critical community preventive and mitigation measures to reduce transmission of infectious diseases, including COVID-19 and other respiratory diseases. WASH guidance…

  13. Journal Article

    Incorporating COVID-19 into Acute Febrile Illness Surveillance Systems, Belize, Kenya, Ethiopia, Peru, and Liberia, 2020–2021

    David C. Shih; Rachel Silver; Olga L. Henao et al.

    Emerging Infectious Diseases, Vol. 28 No. 13 · 2022 · English · DOAJ Scopus

    Existing acute febrile illness (AFI) surveillance systems can be leveraged to identify and characterize emerging pathogens, such as SARS-CoV-2, which causes COVID-19. The US Centers for Disease Control and Prevention collaborated with ministries of health and implementing partners in Belize…